Lawrence Ho

2.3k total citations
31 papers, 1.2k citations indexed

About

Lawrence Ho is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lawrence Ho has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lawrence Ho's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20 papers), Medical Imaging and Pathology Studies (4 papers) and Biomarkers in Disease Mechanisms (3 papers). Lawrence Ho is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20 papers), Medical Imaging and Pathology Studies (4 papers) and Biomarkers in Disease Mechanisms (3 papers). Lawrence Ho collaborates with scholars based in United States, Germany and Netherlands. Lawrence Ho's co-authors include Ganesh Raghu, Bridget F. Collins, Sara Forrester, William J. Canestaro, Eric Schmidt, Kathryn M McDonald, Sara N. Goldhaber-Fiebert, Keith C. Meyer, Martina Vašáková and Danielle Antin‐Ozerkis and has published in prestigious journals such as JAMA, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Lawrence Ho

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence Ho United States 16 774 348 160 156 145 31 1.2k
Megan L. Krause United States 15 363 0.5× 243 0.7× 134 0.8× 259 1.7× 130 0.9× 28 841
C. J. P. Smith United Kingdom 12 932 1.2× 483 1.4× 390 2.4× 72 0.5× 218 1.5× 14 1.6k
Janak de Zoysa New Zealand 19 563 0.7× 151 0.4× 131 0.8× 221 1.4× 34 0.2× 61 1.4k
Deborah Assayag Canada 17 983 1.3× 397 1.1× 227 1.4× 154 1.0× 97 0.7× 54 1.2k
Muhammad K Nisar United Kingdom 15 657 0.8× 386 1.1× 267 1.7× 380 2.4× 47 0.3× 63 1.3k
Nurhan Seyahi Türkiye 17 548 0.7× 79 0.2× 95 0.6× 272 1.7× 88 0.6× 107 1.3k
Charles S. Dayton United States 18 851 1.1× 399 1.1× 100 0.6× 55 0.4× 141 1.0× 24 1.1k
Michael Studnicka Austria 17 909 1.2× 294 0.8× 97 0.6× 37 0.2× 42 0.3× 66 1.3k
J. Oristrell Spain 17 404 0.5× 90 0.3× 94 0.6× 347 2.2× 97 0.7× 38 1.2k
Valérie Patenaude Canada 17 373 0.5× 228 0.7× 294 1.8× 37 0.2× 133 0.9× 31 1.4k

Countries citing papers authored by Lawrence Ho

Since Specialization
Citations

This map shows the geographic impact of Lawrence Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Ho more than expected).

Fields of papers citing papers by Lawrence Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Ho. The network helps show where Lawrence Ho may publish in the future.

Co-authorship network of co-authors of Lawrence Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Ho. A scholar is included among the top collaborators of Lawrence Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Ho. Lawrence Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ho, Lawrence, Nishant Gupta, Joel Moss, et al.. (2024). Unsupervised Exercise in Interstitial Lung Disease. CHEST Journal. 166(5). 1108–1123. 2 indexed citations
3.
Kim, Paul, Siwei Luo, Kevin J. McQuade, et al.. (2023). A remote monitoring-enabled home exercise prescription for patients with interstitial lung disease at risk for exercise-induced desaturation. Respiratory Medicine. 218. 107397–107397. 8 indexed citations
4.
Wu, Wei, Bridget F. Collins, Gregory C. Gardner, et al.. (2023). Antisynthetase syndrome–related interstitial lung disease (ASyS-ILD): longitudinal imaging findings. European Radiology. 33(7). 4746–4757. 5 indexed citations
5.
Ho, Lawrence, et al.. (2023). Management of Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: A Focus on the Role of the Pharmacist. PubMed. Volume 12. 101–112. 1 indexed citations
6.
Raghu, Ganesh, Mark J. Hamblin, Alison Brown, et al.. (2022). Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study. Respiratory Research. 23(1). 129–129. 25 indexed citations
7.
Scallan, Ciaran, Jennifer Hayes, Suha Kadura, et al.. (2021). R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life. European Respiratory Journal. 59(1). 2100917–2100917. 11 indexed citations
8.
Petek, Bradley J., David G. Rosenthal, Kristen K. Patton, et al.. (2018). Cardiac sarcoidosis: Diagnosis confirmation by bronchoalveolar lavage and lung biopsy. Respiratory Medicine. 144. S13–S19. 15 indexed citations
9.
Collins, Bridget F., Robyn L. McClelland, Lawrence Ho, et al.. (2018). Sarcoidosis and IPF in the same patient-a coincidence, an association or a phenotype?. Respiratory Medicine. 144. S20–S27. 36 indexed citations
10.
Collins, Bridget F., Charles Spiekerman, Lawrence Ho, et al.. (2017). Idiopathic Interstitial Pneumonia Associated With Autoantibodies. CHEST Journal. 152(1). 103–112. 34 indexed citations
11.
Raghu, Ganesh, Ellen Morrow, Bridget F. Collins, et al.. (2016). Laparoscopic anti-reflux surgery for idiopathic pulmonary fibrosis at a single centre. European Respiratory Journal. 48(3). 826–832. 30 indexed citations
12.
Canestaro, William J., et al.. (2016). Drug Treatment of Idiopathic Pulmonary Fibrosis. CHEST Journal. 149(3). 756–766. 150 indexed citations
13.
Collins, Bridget F., et al.. (2015). Rheumatoid arthritis-associated lung disease. European Respiratory Review. 24(135). 1–16. 239 indexed citations
14.
Canestaro, William J., Sara Forrester, Lawrence Ho, & Beth Devine. (2015). Drug Therapy for Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review And Network Meta-Analysis. Value in Health. 18(3). A170–A170. 2 indexed citations
15.
Ghebremariam, Yohannes T., John P. Cooke, Melanie Doyle‐Eisele, et al.. (2015). Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis. Journal of Translational Medicine. 13(1). 249–249. 96 indexed citations
16.
Chang, Wenteh, Ke Wei, Lawrence Ho, et al.. (2014). A Critical Role for the mTORC2 Pathway in Lung Fibrosis. PLoS ONE. 9(8). e106155–e106155. 48 indexed citations
17.
Ramnath, Venktesh R., Lawrence Ho, Lauren A. Maggio, & Nayer Khazeni. (2014). Centralized Monitoring and Virtual Consultant Models of Tele-ICU Care: A Systematic Review. Telemedicine Journal and e-Health. 20(10). 936–961. 24 indexed citations
18.
Schmidt, Eric, Sara N. Goldhaber-Fiebert, Lawrence Ho, & Kathryn M McDonald. (2013). Simulation Exercises as a Patient Safety Strategy. Annals of Internal Medicine. 6 indexed citations
19.
Ho, Lawrence, Ruth A. Engelberg, J. Randall Curtis, et al.. (2011). Comparing clinician ratings of the quality of palliative care in the intensive care unit*. Critical Care Medicine. 39(5). 975–983. 27 indexed citations
20.
Ho, Lawrence, Ruth A. Engelberg, J. Randall Curtis, et al.. (2010). Comparing Clinician Ratings Of The Quality Of Palliative Care In The Intensive Care Unit. A6859–A6859. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megan L. Krause Breakdown of academic impact, for papers by C. J. P. Smith Breakdown of academic impact, for papers by Janak de Zoysa Breakdown of academic impact, for papers by Deborah Assayag Breakdown of academic impact, for papers by Muhammad K Nisar Breakdown of academic impact, for papers by Nurhan Seyahi Breakdown of academic impact, for papers by Charles S. Dayton Breakdown of academic impact, for papers by Michael Studnicka Breakdown of academic impact, for papers by J. Oristrell Breakdown of academic impact, for papers by Valérie Patenaude
Rankless by CCL
2026